Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan McLaughlin

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical Chemistry|February 20, 2010
Point: The reporting of estimated glucose with hemoglobin A1cDavid B Sacks, Richard M Bergenstal, Susan McLaughlin
BMC Cancer|March 21, 2025
The psychosocial impact of pancreatic cancer on caregivers: a scoping reviewTara Anderson, Gary Mitchell, Gillian Prue, et al.
BMC Cancer|December 19, 2024
Exploring the supportive care needs of families affected by pancreatic cancer: a mixed-methods study protocolTara Anderson, Gillian Prue, Lisa Graham-Wisener, et al.
Diabetes Research and Clinical Practice|September 18, 2023
Diabetes care and education training audit for primary care physicians across 47 counties of Kenya: A pre-post intervention studySameer Pathan, Luis Gardete, Erick Njenga, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Pancreatic Cancer Education: A Scoping Review of Evidence Across Patients, Professionals and the PublicOlivia Watson, Gary Mitchell, Tara Anderson, et al.
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Annals of Surgical Oncology|January 19, 2006
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II reportLeonard R Henry, Melvyn Goldberg, Walter Scott, et al.
Eclinicalmedicine|July 2, 2025
Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease frameworkKatrin Burkart, Caihua Liang, Quinn Rafferty, et al.
Scientific Reports|August 7, 2025
A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancerPaula Portal Teixeira, Yvonne Yiru Xu, Aleksandr Aravkin, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical Chemistry|February 20, 2010
Point: The reporting of estimated glucose with hemoglobin A1cDavid B Sacks, Richard M Bergenstal, Susan McLaughlin
BMC Cancer|March 21, 2025
The psychosocial impact of pancreatic cancer on caregivers: a scoping reviewTara Anderson, Gary Mitchell, Gillian Prue, et al.
BMC Cancer|December 19, 2024
Exploring the supportive care needs of families affected by pancreatic cancer: a mixed-methods study protocolTara Anderson, Gillian Prue, Lisa Graham-Wisener, et al.
Diabetes Research and Clinical Practice|September 18, 2023
Diabetes care and education training audit for primary care physicians across 47 counties of Kenya: A pre-post intervention studySameer Pathan, Luis Gardete, Erick Njenga, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Pancreatic Cancer Education: A Scoping Review of Evidence Across Patients, Professionals and the PublicOlivia Watson, Gary Mitchell, Tara Anderson, et al.
American Journal of Clinical Oncology|April 1, 2008
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumorsSteven J Cohen, Paul F Engstrom, Nancy L Lewis, et al.
Annals of Surgical Oncology|January 19, 2006
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II reportLeonard R Henry, Melvyn Goldberg, Walter Scott, et al.
Eclinicalmedicine|July 2, 2025
Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease frameworkKatrin Burkart, Caihua Liang, Quinn Rafferty, et al.
Scientific Reports|August 7, 2025
A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancerPaula Portal Teixeira, Yvonne Yiru Xu, Aleksandr Aravkin, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumorsCrystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Pageof 5